Respiratory Infections News

The COVID-19 pandemic has been described by Anthony S. Fauci, MD, as “the most catastrophic acute infectious disease outbreak” in more than a century.

Inpatient antimicrobial use in U.S. hospitals increased both overall and among specific commonly used antibiotics during peak waves of the COVID-19 pandemic, researchers reported.

A large study found that long COVID-related conditions may persist among patients for as long as 2 years after recovery from acute disease, with COVID-19-related hospitalization increasing the risk sharply.

If given to patients with early and symptomatic COVID-19, treatment with remdesivir can accelerate the rate of viral clearance in oropharyngeal swabs over 1 week, researchers found.

CDC advisors will meet next month to vote on recommendations for the updated COVID-19 vaccines that are expected to be available in the United States this fall, according to a notice published Friday in the Federal Register.

A study of more than 30,000 hospitalized children with SARS-CoV-2 infection found that ICU admissions for COVID-19 decreased over the course of the pandemic but ventilatory and oxygen support for the youngest children did not.

Novavax on Tuesday said its updated COVID-19 vaccine candidate induced neutralizing antibodies against emerging SARS-CoV-2 subvariants in small animal and non-human primate studies.

The FDA has approved the first vaccine for pregnant people to protect infants from respiratory syncytial virus.

Why am I hooked on ID? It’s a great question! It might sound clichéd, but my love for this specialty grew as I turned 10.

Moderna this week said preliminary clinical trial data confirmed that its updated COVID-19 vaccine provides a “significant boost” in neutralizing antibodies against emerging SARS-CoV-2 viruses and is expected to effectively target them.